ロード中...
(89)Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I
RATIONALE: Epidermal growth factor receptor (EGFR) upregulation is associated with enhanced proliferation and drug resistance in a number of cancers. Nimotuzumab is a humanized monoclonal antibody with high affinity for EGFR. The objective of this study was to determine if (89)Zr-DFO-nimotuzumab cou...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5908310/ https://ncbi.nlm.nih.gov/pubmed/29682209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24965 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|